Timing And Typology of ConducTIon disturbanCes During TAVI
TACTIC-TAVI
1 other identifier
observational
490
1 country
1
Brief Summary
The TACTIC-TAVI registry aims to collect information about a consecutive cohort of patients undergoing transcatheter aortic valve insertion. The registry is international, multi-centre and observational. The registry is planned to continue until the calculated sample size is achieved.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2023
CompletedFirst Submitted
Initial submission to the registry
July 15, 2024
CompletedFirst Posted
Study publicly available on registry
July 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJuly 22, 2024
July 1, 2024
1.9 years
July 15, 2024
July 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prediction of new requirement for permanent pacemaker after TAVI
The primary focus of the registry is evaluating which patient characteristics and conduction disturbances may help to predict the new requirement for permanent pacemaker after TAVI.
0-24 months
Eligibility Criteria
The study is a retrospective and prospective registry aiming to observe intra-procedural conduction disturbances in patients undergoing TAVI for severe aortic stenosis. Patients will have no alteration to standard post-procedural management and will their have usual follow-up. There are four key time points: 1) pre-procedure 2) intra-procedure 3) post-procedure 4) discharge. The electrocardiogram will be assessed at timepoints 1-3 and requirement for permanent pacemaker insertion by timepoint 4.
You may qualify if:
- Patients successfully undergoing transcatheter aortic valve implantation for native severe aortic stenosis.
You may not qualify if:
- Presence of previously implanted permanent cardiac pacemaker.
- Valve-in-valve procedures.
- No pre-procedural electrocardiogram is available.
- No pre-procedural contrast CT TAVI is available.
- Enrollment in another clinical trial.
- Patients aged less than 18 years old.
- Patients who do not consent for their data to be included in the registry.
- Failed transcatheter aortic valve deployment. -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Istituo Clinico Humanitas
Rozzano, Milano, 20089, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Antonio Mangieri, MD
Humanitas Research Horspital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 15, 2024
First Posted
July 18, 2024
Study Start
February 1, 2023
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
July 22, 2024
Record last verified: 2024-07